Crossmark

Efficient and selective antibody modification with functionalised divinyltriazines

Crossref DOI link: https://doi.org/10.1039/D0OB01002B

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Counsell, Andrew J. https://orcid.org/0000-0003-0245-2329
Walsh, Stephen J. https://orcid.org/0000-0002-3164-1519
Robertson, Naomi S. https://orcid.org/0000-0001-5519-9158
Sore, Hannah F. https://orcid.org/0000-0002-6542-0394
Spring, David R. https://orcid.org/0000-0001-7355-2824
Funding

Funding for this research was provided by:

Engineering and Physical Sciences Research Council (EP/P020291/1)

Royal Society (Wolfson Research Merit Award)
License Information

Version of Record valid from 2020-06-10
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Andrew J. Counsell (ORCID)

: Stephen J. Walsh (ORCID)

: Naomi S. Robertson (ORCID)

: Hannah F. Sore (ORCID)

: David R. Spring (ORCID)

: David R. Spring (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 15 May 2020; Accepted 10 June 2020; Accepted Manuscript published 10 June 2020; Advance Article published 17 June 2020; Version of Record published 1 July 2020